Molecular and Systems Pharmacology (GDBBS)

The Molecular and Systems Pharmacology (MSP) graduate program at Emory University has a great deal to offer students interested in learning how the drugs of today work and how the novel therapeutics of tomorrow can revolutionize healthcare. The program also offers broad training in the biomedical sciences that prepares students for diverse careers in medical research.

Each year brings the development of exciting new therapeutics in the treatment of cancer, heart disease, AIDS, diabetes, psychiatric disorders, and other diseases. Pharmacology seeks to understand how such therapeutics work and to use this knowledge, along with techniques such as molecular modeling and computer-aided design, to develop new ideas that may lead to the revolutionary drugs of the future. Pharmacology also includes toxicology, the study of the adverse effects of certain drugs and environmental pollutants.

Emory University was recently rated by The Scientist magazine as the #1 university in the world in terms of impact in pharmacology and toxicology research. Particular strengths within the MSP program include neuropharmacology, cancer biology, AIDS research, cardiovascular pharmacology, toxicology, and chemical biology. Trends in NIH funding rank Emory among the fastest growing medical centers in the USA. 

Molecular and Systems Pharmacology (MSP) is one of eight interdisciplinary programs in the Graduate Division of Biological and Biomedical Sciences (GDBBS).